Table IV.
Histology | No. of patients | Interval from the end of first-line treatment to relapse (months) | ||
---|---|---|---|---|
| ||||
<6 | 6–12 | >12 | ||
Serous | 73 | 10 (14%) | 27 (37%) | 36 (49%) |
Endometrioid | 12 | 3 (25%) | 3 (25%) | 6 (50%) |
Clear cell | 16 | 5 (31%) | 6 (38%) | 5 (31%) |
Mucinous | 6 | 2 (33%) | 1 (17%) | 3 (50%) |